Obermatt
See Similar Stocks →

Flags

Financial distress

Mesa Laboratories

NSQ:MLAB · US59064R1095
Life Sciences Tools & ServicesSmall

360

69
EV / EBIT90
Price / Owner Earnings28
Owner Earnings Yield91
Dividend Yield91
Price/Sales83
EV / Gross Profit84
Price/Book54
Return on Capital66
Cash Return on Capital87
Return on Equity74
EBIT Margin61
Gross Profitability82
Cash Conversion96
Accruals53
Owner Earnings Margin80
Sales growth37
Profit Growth99
Long-Term EPS Growth21
Owner Earnings Growth76
Reinvestment67
Price momentum33
Debt load30
Refinancing57
Debt Payback30
Liquidity45
Analyst ratings19
Opinion Changes50
Price Target Upside20
Market mood17
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Mesa Laboratories clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1982
Employees272
Websitemesalabs.com
ISINUS59064R1095
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Environment, Health and Safety (EH&S)Detectors, Sensors and MemsProcess AutomationHealth DiagnosticsPollution ControlBiomedical EngineeringGeneticsBiotechnologyManufacturingMedical DeviceRoboticsTest and Measurement

Description

Mesa Laboratories, Inc. and its subsidiaries (Mesa) is a global leader in the design and manufacture of life sciences tools, as well as critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical devic…

Analysis

Quality compounder

Mesa Laboratories, Inc. earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess.

On valuation, the picture is fair. The owner-earnings multiple stands at 22.1×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is stretched. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
45
2023202420252026

All-time high

51

Jan 2023

All-time low

15

Jan 2024

Average rank

34

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
50
59
31
Price/Earnings
6
54
10
14
Price/Book
54
41
85
65
Dividend Yield
91
86
89
88
Value (overall)
89
75
81
63

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Mesa Laboratories with its peers
Illumina
NSQ:ILMN
77
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Cytek Biosciences
NSQ:CTKB
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Avantor
NYQ:AVTR
13
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Rapid Micro Biosystems
NAQ:RPID
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Bio-Techne
NSQ:TECH
74
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Azenta
NSQ:AZTA
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →